PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL): a pooled analysis - Long, Georgina; Hassel, Jessica C. (Annals of oncology, 2016)
Gesehen am 10.11.2017